• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】22701

【品名】4-hydroxy-3-methoxybenzaldehyde

【CA登记号】121-33-5

【 分 子 式 】C8H8O3

【 分 子 量 】152.14972

【元素组成】C 63.15% H 5.3% O 31.55%

与该中间体有关的原料药合成路线共 10 条

合成路线1

该中间体在本合成路线中的序号:(I)

Synthesis of curcumin was first described by Lampe et al. In our laboratory curcumin has been synthesized by condensing vanillin (I) and acetyl acetone (II) in a medium of ethyl acetate using tributylborate as boron complex to avoid Knoevenagel condensation at C-3 of acetyl acetone. Curcumin is isolated from the reaction mixture by acidification and extraction with ethyl acetate. The organic layers are washed until neutral, dried and the solvent is removed. purified by chromatography over silica gel using ether/petroleum ether as the solvent.

1 Scrimal, R.C.; Curcumin. Drugs Fut 1987, 12, 4, 331.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 16620 3-[(3R,4R)-3,4-dimethylhexahydro-4-pyridinyl]phenol 119193-19-0 C13H19NO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VI)

The protection of 4-bromo-2-methoxyphenol (I) with ethyl vinyl ether (II) and TsOH in dichloromethane gives the ethoxyethyl ether (III), which is treated with n-BuLi in THF to yield the phenyl lithium compound (IV). The reaction of (IV) with 2H-labeled DMF (V), followed by hydrolysis with HCl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (VI), which is finally condensed with pentane-2,4-dione (VII) by means of B2O3 and tetrahydroquinoline in DMF.

1 Threadgill, M.D.; Parveen, I.; Labelled compounds of interest as antitumour agents - VII. [H-2]- and [C-14]-curcumin. J Label Compd Radiopharm 2000, 43, 9, 883.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 45436 4-bromo-2-methoxyphenol 7368-78-7 C7H7BrO2 详情 详情
(II) 18762 1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene 109-92-2 C4H8O 详情 详情
(III) 45437 5-bromo-2-(1-ethoxyethoxy)phenyl methyl ether; 4-bromo-1-(1-ethoxyethoxy)-2-methoxybenzene C11H15BrO3 详情 详情
(IV) 45438 [4-(1-ethoxyethoxy)-3-methoxyphenyl]lithium C11H15LiO3 详情 详情
(V) 33491 Dimethylformamide 68-12-2 C3H7NO 详情 详情
(V) 45439 dimethylformamide C3H7NO 详情 详情
(VI) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(VI) 45440 4-hydroxy-3-methoxybenzaldehyde 21-59-0 C8H8O3 详情 详情
(VII) 11620 2,4-Pentanedione;acetylacetone 123-54-6 C5H8O2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VI)

The protection of 4-bromo-2-methoxyphenol (I) with ethyl vinyl ether (II) and TsOH in dichloromethane gives the ethoxyethyl ether (III), which is treated with n-BuLi in THF to yield the phenyl lithium compound (IV). The reaction of (IV) with 14C-labeled DMF (V), followed by hydrolysis with HCl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (VI), which is finally condensed with pentane-2,4-dione (VII) by means of B2O3 and tetrahydroquinoline in DMF.

1 Threadgill, M.D.; Parveen, I.; Labelled compounds of interest as antitumour agents - VII. [H-2]- and [C-14]-curcumin. J Label Compd Radiopharm 2000, 43, 9, 883.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 45436 4-bromo-2-methoxyphenol 7368-78-7 C7H7BrO2 详情 详情
(II) 18762 1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene 109-92-2 C4H8O 详情 详情
(III) 45437 5-bromo-2-(1-ethoxyethoxy)phenyl methyl ether; 4-bromo-1-(1-ethoxyethoxy)-2-methoxybenzene C11H15BrO3 详情 详情
(IV) 45438 [4-(1-ethoxyethoxy)-3-methoxyphenyl]lithium C11H15LiO3 详情 详情
(V) 33491 Dimethylformamide 68-12-2 C3H7NO 详情 详情
(V) 45441 dimethylformamide C3H7NO 详情 详情
(VI) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(VI) 45442 4-hydroxy-3-methoxybenzaldehyde C8H8O3 详情 详情
(VII) 11620 2,4-Pentanedione;acetylacetone 123-54-6 C5H8O2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

TMK 688 is derived trom the condensation ot 5-(3'-methoxy-4'-hydroxyphenyl)-2,4-pentadienoic acid (IV) and N-aminoethyl 4-diphenylmethoxypiperidine (X) in the presence of ethyl chloroformate in dichloromethane. Synthesis of intermediate (IV): Vanillin (I) is protected with ethyl chloroformate to give (II), which is then treated with triethyl 4-phosphonocrotonate and followed by alkali hydrolysis to produce (IV).

1 Tasaka, K.; TMK-688. Drugs Fut 1988, 13, 12, 1056.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 22705 ethyl (E)-4-(diethoxyphosphoryl)-2-butenoate C10H19O5P 详情 详情
(B) 22706 5-[4-(Ethoxycarbonyl)-3-methoxyphenyl]-2(E),4(E)-pentadienoic acid ethoxycarbonyl anhydride C18H20O7 详情 详情
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 22702 ethyl 4-formyl-2-methoxyphenyl carbonate C11H12O5 详情 详情
(III) 22703 ethyl (2E,4E)-5-[4-[(ethoxycarbonyl)oxy]-3-methoxyphenyl]-2,4-pentadienoate C17H20O6 详情 详情
(IV) 22704 (2E,4E)-5-(4-hydroxy-3-methoxyphenyl)-2,4-pentadienoic acid C12H12O4 详情 详情
(X) 22707 2-[4-(benzhydryloxy)-1-piperidinyl]ethylamine; 2-[4-(benzhydryloxy)-1-piperidinyl]-1-ethanamine C20H26N2O 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

The condensation of 4-hydroxy-3-methoxybenzaldehyde (I) with ethyl cyanoacetate (II) by means of NaOH in ethanol gives the 2-cyanopropenoate (III), which is then alkylated at the OH group with ethyl 2-bromoacetate (IV) by means of K2CO3 and tetrabutylammonium bromide in THF.

1 Tiwari, S.; et al.; Synthesis and antileishmanial activity of alpha-cyano ethyl propenoates - A new class of antileishmanials. Arzneim-Forsch Drug Res 1999, 49, 2, 144.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(III) 30896 ethyl (Z)-2-cyano-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate C13H13NO4 详情 详情
(IV) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

Protection of vanillin (I) as the benzyl ether (II), followed by reaction with benzylmagnesium bromide, furnished alcohol (III). Oxidation of alcohol (III) to the corresponding ketone (IV) was achieved by means of chromium trioxide or, in an improved procedure, by Oppenauer oxidation with cyclohexanone and sodium tert-butoxide. Benzyl group cleavage in (IV) either with HBr, or by transfer hydrogenolysis, yielded phenol (V). Regioselective nitration of (V) gave the ortho-nitrophenol (VI). The title compound was finally obtained by methyl ether cleavage in (VI) with boiling HBr or with AlCl3 in pyridine.

1 Benes, J.; Vieira-Coelho, M.A.; Borges, N.; Freitas, A.P.; Soares-da-Silva, P.; Alves, P.C.; Learmonth, D.A.; Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase. J Med Chem 2002, 45, 3, 685.
3 Benes, J.; Soares da Silva, P.M.V.A.; Learmonth, D.A. (Portela & Ca., SA); Substd. 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compsns. containing them. EP 1010688; GB 2344819; WO 0037423 .
2 Learmonth, D.; et al.; Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and selective inhibitors of catechol-O-methyltransferase (COMT). 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PA-34.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 14045 4-(Benzyloxy)-3-methoxybenzaldehyde; 4-Benzyloxy-3-methoxybenzaldehyde 2426-87-1 C15H14O3 详情 详情
(III) 59403 1-[4-(benzyloxy)-3-methoxyphenyl]-2-phenyl-1-ethanol C22H22O3 详情 详情
(IV) 59404 1-[4-(benzyloxy)-3-methoxyphenyl]-2-phenyl-1-ethanone C22H20O3 详情 详情
(V) 59405 1-(4-hydroxy-3-methoxyphenyl)-2-phenyl-1-ethanone C15H14O3 详情 详情
(VI) 59406 1-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-phenyl-1-ethanone C15H13NO5 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

The condensation of vanillin (I) with epichlorohydrin (II) in ethanolic NaOH produced the glycidyl ether (III). Epoxide ring opening in (III) by means of tert-butylamine (IV) in EtOH furnished amino alcohol (V). The title dihydropyridine derivative was then obtained by reaction between aldehyde (V), methyl acetoacetate (VI), ammonia under Hantzsch condensation conditions, and was isolated after conversion to the hydrochloride salt.

1 Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719.
2 Donovan, S. (Allergan, Inc.); Method for treating a neoplasm. WO 0209743 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(III) 59599 3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde C11H12O4 详情 详情
(IV) 17895 2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine 75-64-9 C4H11N 详情 详情
(V) 59600 4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-methoxybenzaldehyde C15H23NO4 详情 详情
(VI) 11791 methyl 3-oxobutanoate; Methyl acetoacetate 105-45-3 C5H8O3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(I)

Vanillin (I) was protected as the tetrahydropyranyl ether (II) by treatment with dihydropyran in the presence of pyridinium p-toluenesulfonate. Similarly, hydroxyacetone (III) was converted to the corresponding tetrahydropyranyl ether (IV). Aldol condensation between aldehyde (II) and ketone (IV) using LDA in cold THF furnished the hydroxy ketone (V). Removal of the tetrahydropyranyl protecting groups of (V) under acidic conditions caused the dehydration of the beta-hydroxyl group, affording the unsaturated ketone (VI). The phenolic hydroxyl group of (VI) was then protected as the trimethylsilyl ether (VII). After protection of the phenolic hydroxyl group of ferulic acid (VIII) as the silyl ether (IX), coupling between (IX) and (VII) by means of DCC and DMAP provided the silyl-protected ester (X). This was finally desilylated by treatment with HOAc in aqueous THF.

1 Kim, D.S.H.L. (University of Illinois); Pharmaceutical compsns. useful in the prevention and treatment of beta-amyloid protein-induced disease. WO 0130335 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 52071 3-methoxy-4-(tetrahydro-2H-pyran-2-yloxy)benzaldehyde C13H16O4 详情 详情
(III) 52072 1-hydroxyacetone 116-09-6 C3H6O2 详情 详情
(IV) 52073 1-(tetrahydro-2H-pyran-2-yloxy)acetone C8H14O3 详情 详情
(V) 52074 4-hydroxy-4-[3-methoxy-4-(tetrahydro-2H-pyran-2-yloxy)phenyl]-1-(tetrahydro-2H-pyran-2-yloxy)-2-butanone C21H30O7 详情 详情
(VI) 52075 (E)-1-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one C11H12O4 详情 详情
(VII) 52076 (E)-1-hydroxy-4-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-3-buten-2-one C14H20O4Si 详情 详情
(VIII) 48091 (E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid 1135-24-6 C10H10O4 详情 详情
(IX) 52077 (E)-3-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-2-propenoic acid C13H18O4Si 详情 详情
(X) 52078 (E)-4-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-2-oxo-3-butenyl (E)-3-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-2-propenoate C27H36O7Si2 详情 详情

合成路线9

该中间体在本合成路线中的序号:(VII)

The condensation of vanillin (VII) with epichlorohydrin (VIII) in ethanolic NaOH produced the glycidyl ether (IX). Epoxide ring opening in (IX) by means of amine (VI) in EtOH furnished amino alcohol (X). The title dihydropyridine derivative was then obtained by reaction between aldehyde (X), methyl acetoacetate (XI), and ammonia under Hantzsch condensation conditions.

1 Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719.
2 Lin, T.-H.; Chen, I.-J.; Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity. EP 1108710; WO 0005209 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 31105 2-(2-methoxyphenoxy)ethylamine; 2-(2-methoxyphenoxy)-1-ethanamine 1836-62-0 C9H13NO2 详情 详情
(VII) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(VIII) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(IX) 59599 3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde C11H12O4 详情 详情
(X) 59618 4-(2-hydroxy-3-{[2-(2-methoxyphenoxy)ethyl]amino}propoxy)-3-methoxybenzaldehyde C20H25NO6 详情 详情
(XI) 11791 methyl 3-oxobutanoate; Methyl acetoacetate 105-45-3 C5H8O3 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

 

1 Cziaky Z 2006.Process for the preparation of entacapone in a stable polymorphic form and preparation of intermediates for its preparation. W0 2006064296
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(II) 15283 2-cyano-N,N-diethylacetamide 26391-06-0 C7H12N2O 详情 详情
(III) 66319 2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide   C15H18N2O3 详情 详情
(IV) 66318 2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylamide   C15H17N3O5 详情 详情
Extended Information